| in EUR thousand |
1.1.-30.9.2018 |
1.1.-30.9.20171 |
| I. Cash flow from operating activities |
|
|
| Net income |
788,843 |
609,699 |
| Appreciation/depreciation |
59,548 |
29,234 |
| Net realised gains and losses on investments |
(100,835) |
(343,256) |
| Change in fair value of financial instruments (through profit or loss) |
(19,890) |
(22,114) |
| Realised gains and losses on deconsolidation |
(2,492) |
– |
| Amortisation of investments |
5,208 |
42,807 |
| Changes in funds withheld |
(363,424) |
77,834 |
| Net changes in contract deposits |
(219,515) |
58,625 |
| Changes in prepaid reinsurance premium (net) |
839,459 |
607,406 |
| Changes in tax assets/provisions for taxes |
(16,074) |
(107,555) |
| Changes in benefit reserve (net) |
249,842 |
(543,961) |
| Changes in claims reserves (net) |
1,155,527 |
1,783,412 |
| Changes in deferred acquisition costs |
(258,147) |
(138,395) |
| Changes in other technical provisions |
114,273 |
35,207 |
| Changes in clearing balances |
(746,539) |
(608,716) |
| Changes in other assets and liabilities (net) |
223,382 |
(11,493) |
| Cash flow from operating activities |
1,709,166 |
1,468,734 |
| II. Cash flow from investing activities |
(1,824,437) |
(682,501) |
| III. Cash flow from financing activities |
150,382 |
(686,791) |
| |
|
|
| IV. Exchange rate differences on cash |
14,131 |
(55,843) |
| Cash and cash equivalents at the beginning of the period |
835,706 |
848,667 |
| Change in cash and cash equivalents (I. + II. + III. + IV.) |
49,242 |
43,599 |
| Cash and cash equivalents at the end of the period |
884,948 |
892,266 |
| thereof cash and cash equivalents from IFRS 5 |
66,272 |
– |
| Cash and cash equivalents at the end of the period excluding the disposal group |
818,676 |
892,266 |
| |
|
|
| Supplementary information on the cash flow statement2 |
|
|
| Income taxes paid (on balance) |
(317,401) |
(264,597) |
| Dividend receipts3 |
166,892 |
180,062 |
| Interest received |
1,164,056 |
1,198,566 |
| Interest paid |
(249,940) |
(225,413) |
